Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05585996. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04183569. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT05410041. IPD Sharing: NO. Countries: 1. Publications: 0.
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
ClinicalTrials.gov study NCT05010564. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL
ClinicalTrials.gov study NCT04303247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
ClinicalTrials.gov study NCT07283315. IPD Sharing: NO. Countries: 1. Publications: 0.
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05348213. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
ClinicalTrials.gov study NCT03614858. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality
ClinicalTrials.gov study NCT05095155. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
ClinicalTrials.gov study NCT06641024. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
ClinicalTrials.gov study NCT05615636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01202448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT07168291. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
ClinicalTrials.gov study NCT05253118. IPD Sharing: NO. Countries: 1. Publications: 0.
Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03472573. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
ClinicalTrials.gov study NCT05233033. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT03271515. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
ClinicalTrials.gov study NCT06356129. IPD Sharing: YES. Countries: 39. Publications: 0.
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
ClinicalTrials.gov study NCT05631912. IPD Sharing: NO. Countries: 1. Publications: 0.
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
ClinicalTrials.gov study NCT04637763. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.